Chemoinformaics analysis of mono [2-ethylhexyl] ester
| Molecular Weight | 278.348 | nRot | 8 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 8 |
| Exact Molecular Weight | 278.152 | nRing | 1 |
| Solubility: LogS | -3.733 | nHRing | 0 |
| Solubility: LogP | 4.315 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 44.5974 |
| nHD | 1 | BPOL | 25.5426 |
| QED | 0.735 |
| Synth | 2.383 |
| Natural Product Likeliness | 0.223 |
| NR-PPAR-gamma | 0.828 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.003 |
| HIA | 0.003 |
| CACO-2 | -4.632 |
| MDCK | 0.0000245 |
| BBB | 0.211 |
| PPB | 0.961913 |
| VDSS | 0.22 |
| FU | 0.0201668 |
| CYP1A2-inh | 0.358 |
| CYP1A2-sub | 0.435 |
| CYP2c19-inh | 0.083 |
| CYP2c19-sub | 0.074 |
| CYP2c9-inh | 0.596 |
| CYP2c9-sub | 0.128 |
| CYP2d6-inh | 0.295 |
| CYP2d6-sub | 0.099 |
| CYP3a4-inh | 0.083 |
| CYP3a4-sub | 0.076 |
| CL | 2.689 |
| T12 | 0.72 |
| hERG | 0.287 |
| Ames | 0.004 |
| ROA | 0.006 |
| SkinSen | 0.174 |
| Carcinogencity | 0.172 |
| EI | 0.983 |
| Respiratory | 0.539 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.773894 |